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Abstract
Background
Single measurements of modifiable risk factors may underestimate associations with out-
comes in cohorts.We aimed to compare risk estimates of myocardial infarction (MI) and
venous thromboembolism (VTE) by atherosclerotic risk factors during long follow-up using
time-fixed analyses without and with correction for regression dilution and time-varying
analyses.
Methods
The study included 5970 subjects enrolled in the fourth survey of the Tromsø Study (1994/
95). Blood pressure, lipid levels, body mass index (BMI), diabetes and smoking status were
measured at baseline, and subjects still alive at the fifth (2001/02, n = 5179) and sixth
(2007/08, n = 4391) survey were re-measured. Incident events of MI (n = 714) and VTE (n =
214) were recorded until December 2010. Time-fixed and time-varyingCox regressionmod-
els were used to estimate hazard ratios (HR) for MI and VTE adjusted for age and sex.
Results
Variations in BMI, blood pressure and lipid levels were small, and did not alter the risk esti-
mates when time-varying analyses were compared to time-fixed analyses. For MI, variables
that changed considerably over time yielded the greatest changes in risk estimates (HR for
smoking changed from 1.80 (95%CI 1.55–2.10) to 2.08 (95%CI 1.78–2.42)). For VTE, only
BMI was associated with increased risk in both time-fixed and time-varying analysis, but the
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risk estimates weakened in the time-varying analysis. Correction of time-fixed HRs with
Rosner´smethod tended to overestimate risk estimates compared to time-varying analysis.
Comment
For MI and VTE, risk estimates based on baseline and repeatedmeasures corresponded
well, whereas correction for regression dilution tended to overestimate risks.
Introduction
Arterial thrombotic disease (e.g. myocardial infarction [MI] and stroke) and venous thrombo-
embolism (VTE) have traditionally been considered separate diseases with different patho-
physiology, but during the last decade studies have supported a bidirectional association
between them [1–4]. Whether the association between arterial and venous thrombosis is causal
or mediated through shared risk factors remains uncertain.Of the traditional cardiovascular
risk factors, only age, obesity and family history of MI have consistently been associated with
VTE [5–10], whereas diabetes, hypertension and dyslipidemia have been associated with VTE
in some [11–15] but not all [6, 16–18] studies. The majority of the studies that found an associ-
ation between atherosclerotic risk factors and VTE were of a retrospective nature [11, 13–15],
whereas most prospective studies reported no association [6, 16–18].
In conventional cohort studies, risk factor levels are usually assessed at the time of inclusion
and related to outcomes occurring several years, or even decades, later. However, the status of a
risk factor may change over time, and these changes usually become greater with time from
exposure assessment. Both the effect of a risk factor (called time-dependent effect) and the
value of the risk factor itself (called time-dependent covariate) can change over time. Random
measurement errors, temporary fluctuations, and true changes in variables over time generally
lead to regression dilution bias [19], a phenomenon that results in underestimation of the true
association between exposure and outcome. As most atherosclerotic risk factors are modifiable,
changes during follow-up may have influenced the risk estimates of MI and VTE in previous
cohort studies. Thus, the absence of an association between atherosclerotic risk factors and
VTE found in cohorts could potentially be explained by regression dilution.
Regression dilution bias is potentially a major limitation of prospective cohorts that could
either be addressed by performing time-varying analysis or correct the risk estimates by a
regression dilution ratio. When a variable is assessed within the same individual at different
time points during the study period, time-varying analysis will allow for changes in exposure
status during follow-up. If repeated measurements exists only for a subsample of individuals
within a cohort, a regression dilution ratio can be calculated and used to correct the risk esti-
mates from time-fixed analyses [20, 21]. Using this approach, a previous study reported that a
single baselinemeasurement of cholesterol and diastolic blood pressure resulted in a respec-
tively 47% and 76% underestimation of the association with coronary heart disease risk in the
third decade of follow-up [22]. Another study reported that baseline assessment of disease risk
underestimated the strength of the real associations by about one-third the first decade, about
one-half the second decade, and about two-thirds the third decade [23]. However, it has been
suggested that simple methods of correction for regression dilution bias may lead to overcor-
rection if the relationship between risk factor and disease is not short term [24].
In a prospective population-based cohort, we therefore aimed to investigate whether the use
of repeated measurements of atherosclerotic risk factors influenced the risk estimates for VTE
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and MI compared to using baselinemeasurements only, with and without correction for the
regression dilution bias. Secondly, we aimed to investigate whether the lack of association
between atherosclerotic risk factors and VTE in previous long-term cohorts could be explained
by regression dilution bias.
Methods
Study population
Participants were recruited from the fourth, fifth and sixth surveys of the Tromsø study (con-
ducted in 1994–1995, 2001–2002 and 2007–2008, respectively). A detailed description of the
Tromsø surveys has been published elsewhere [25]. In brief, the entire population (Tromsø 4)
or parts of the population (Tromsø 5 and 6) aged25 years living in the municipality of
Tromsø, Norway, were invited to participate in these surveys. In Tromsø 4, all men aged 55–74
and women aged 50–74, as well as smaller (5–8%) random samples of other age groups were
invited to a more extensive second examination. All subjects attending the second visit in
Tromsø 4 were re-invited to attend Tromsø 5 and Tromsø 6 if they were still alive and living in
the municipality of Tromsø. Subjects who attended the second phase of Tromsø 4 (n = 6861),
as well as subjects attending the first phase of Tromsø 4 and the two subsequent visits
(n = 418), were considered eligible for the present study. Subjects with VTE (n = 22) or MI
(n = 306) prior to baseline, and subjects not officially registered as inhabitants of the munici-
pality of Tromsø at baseline (n = 7), were excluded. Moreover, subjects who were re-invited
but failed to attend one or more visits were excluded from follow-up (n = 974). Subjects who
died (n = 1142) or moved (n = 437) between two subsequent visits were censored at the date of
death or migration during follow-up. Thus, 5970 participants were included, of which 4391
attended all three surveys (Fig 1). The study was approved by the Regional Committee of Medi-
cal Health Research Ethics North Norway, and all participants provided informedwritten
consent.
Atherosclerotic risk factors
Information on atherosclerotic risk factors was collected by physical examinations, blood sam-
ples and self-administered questionnaires. Similar examinations, blood tests and question-
naires were repeated at each survey. Height and weight were measured with participants
wearing light clothing and no shoes. Bodymass index (BMI) was calculated as weight in
Fig 1. Study population. Study population recruited fromThe Tromsø Study, 1994–2010. Figure showing the common, “basic”, population
in each analysis, and number of incident VTE andMI events (separate analyses for each outcome)
doi:10.1371/journal.pone.0163242.g001
Repeated Measures of Atherosclerotic Risk Factors
PLOSONE | DOI:10.1371/journal.pone.0163242 September 16, 2016 3 / 14
kilograms divided by the square of height in meters (kg/m2). Blood pressure was measured
three times with an automatic device (Dinamap Vital Signs Monitor) in a sitting position after
two minutes of rest. The average of the two last readings was used in the analyses. Non-fasting
blood samples were collected from an antecubital vein and total cholesterol, triglycerides and
high-density lipoprotein (HDL) measured. Self-administered questionnaires were used to
obtain information on diabetes, smoking (current smoker yes/no), physical activity (strenuous
physical activity 1 or more hour per week) and education (over or equal to 15 years of educa-
tion). Hypertension was defined as systolic blood pressure140 mmHg, diastolic blood pres-
sure90 mmHg or current antihypertensive treatment. Overweight (BMI 25–29.9 kg/m2) and
obesity (BMI30 kg/m2) was classified according to theWorld Health Organization (WHO)
definition [26], and hypercholesterolemia was defined as total cholesterol6.5 mmol/L or self-
reported use of lipid-lowering drugs. LowHDL cholesterol was defined as1.03 mmol/L in
men or1.30 mmol/L in women, according to the National Cholesterol Education Program-
Adult Treatment Panel III guidelines [27], as described elsewhere [28].
Identificationand validation of MI
All incident events of MI were identified by searching hospital and out-of hospital medical rec-
ords, autopsy records and death certificates, and all possible events were validated by an inde-
pendent end-point committee. The unique national 11-digit identification number allowed
linkage to national and local diagnosis registries. Possible cases of MI were identified by linkage
to the hospital discharge registry at the University Hospital of North Norway by searching for
relevant International Classification of Diseases, as previously described [29] The hospital
medical records were retrieved for case validation.MI events were validated according to modi-
fiedWorld Health Organization MONICA/MORGAM criteria, including clinical signs and
symptoms, findings in electrocardiograms, values of cardiac biomarkers and autopsy records
when applicable [30]. Further, linkage to the National Causes of Death Registry at Statistics
Norway allowed identification of fatal incident cases of MI that occurred as out-of hospital
deaths, including deaths that occurred outside of Tromsø, as well as information on all-cause
mortality. Information from death certificateswas used to collect relevant information of the
event from additional sources, including autopsy reports and records from nursing homes,
ambulance services and general practitioners.
Identificationand validation of venous thromboembolism
As previously described [31], all incident VTE events were identified by searching the hospital
discharge diagnosis registry, the autopsy registry and the radiology procedure registry at the
University Hospital of North Norway. The University Hospital of North Norway is the only
hospital in the region, and all hospital care and relevant diagnostic radiology is provided exclu-
sively by this hospital. The medical record for each potential case of VTE was reviewed by
trained personnel, and an episode of VTE was confirmed and registered as a validated VTE
event when all of the following four conditions were satisfied: 1) confirmation by objective
diagnostic procedures, including compression ultrasonography, venography, spiral computed
tomography, perfusion-ventilation scan, pulmonary angiography or autopsy; 2) indication in
the medical records that a physician diagnosed deep vein thrombosis or pulmonary embolism;
3) presence of clinical signs and symptoms consistent with deep vein thrombosis or pulmonary
embolism; and 4) treatment with anticoagulants (heparin, warfarin), thrombolytic therapy or
vascular surgery was required unless contraindications were specified [31]. VTE cases from the
autopsy registrywere recorded when the death certificate indicated VTE as the cause of death,
or a significant condition associated with death.
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Statistical analysis
Statistical analyses were performedwith STATA version 13.0 (Stata Corporation, College Sta-
tion, TX, USA) and the figure showing intra-individual variability (Fig 2) was made using
GraphPad Prism version 5.04 for Windows (GraphPad Software, San Diego CaliforniaUSA,
www.graphpad.com). The significance level was set to 0.05. Follow-up time and risk estimates
for VTE and MI were calculated separately. Atherosclerotic risk factors were measured at base-
line (1994–1995), and subjects still living in the municipality of Tromsø at the fifth (2001–
2002, n = 5179) and sixth (2007–2008, n = 4391) survey of the Tromsø study were re-mea-
sured. For each participant, person-years of follow-up were counted from the date of enroll-
ment (1994–1995) to the date of an incident VTE or MI event (one analysis for each end-
point), the date the participant died or moved from the municipality of Tromsø, or until the
end of the study period (December 31, 2010), whichever came first. Age was used as time-scale
and the entry and exit time was defined as the participants’ age at study enrollment and censor-
ing event (MI, VTE, death, migration or end of study). We used three different approaches to
calculate hazard ratios (HRs) of MI and VTE: (i) time-fixed analysis, (ii) correcting for time-
dependent covariates using a regression dilution ratio, and (iii) time-varying analysis. In the
first approach, we used a traditional Cox proportional hazard regression model that included
baselinemeasurements from Tromsø 4. HRs with 95% confidence intervals (CI) for MI and
VTE, adjusted for age as time scale and sex, were calculated. In the second approach, HRs
Fig 2. Intra-individual variability over time.Subjects were divided into quintiles at baseline in Tromsø 4
according to their baseline value of a certain risk factor. Themean value in each group is represented in the figure.
Values were updated after approximately 7 and 13 years, in Tromsø 5 and Tromsø 6, respectively.
doi:10.1371/journal.pone.0163242.g002
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calculated from traditional Cox proportional hazard regression models based on baselinemea-
surements were corrected by a regression dilution ratio calculated by Rosner´s method for
repeated measurements [32, 33]. This was done by multiplying the hazard coefficients of the
normal time-fixedCox regression model by the estimated regression dilution bias coefficient.
The regression dilution bias coefficientwas found as the inverse of the slope of the linear
regression line of risk factor measurement of Tromsø 4 vs. Tromsø 5. The measurement time
in Tromsø 5 was chosen (ignoring Tromsø 6) as the dependent value of the regression as it was
approximately midway between the start and end of the study, as suggested by Clarke et al.
[23]. In the last approach, a time-varyingCox proportional hazards regression analysis was
used. Here, each participant contributed with one or more observation periods and each period
lasted from one measurement until the next (i.e. from T4 to T5, from T5 to T6, and from T6
until the end of study the study period). The 5970 participants contributed with 15101 and
15403 observation periods in the MI and VTE analysis, respectively. The risk factors were
updated at everymeasurement and used as time-dependent covariates in the analysis. The
number of subjects included in the analyses of each risk factor varied slightly due to missing
data for covariates (< 2%missing).
Joint modelling of repeated measurements and time-to-event data was considered, but
found unsuitable due to convergence issues, as our dataset contained several participants with
only one or two repeated measurements, particularly among those who experienced a VTE or
MI event.
The proportional hazards assumption for the different risk factors was tested by evaluating
the parallelism between curves of the log-log survivor function. The assumption was verified
for all risk factors associated with VTE. For MI, the assumption was verifiedwhen stratifying
by age (over and under 60 years old).
Results
Among the 5970 participants, 741 subjects had an incident MI and 214 subjects an incident
VTE during a median follow-up time of 15.7 years. The distribution of atherosclerotic risk fac-
tors in the three different surveys is shown in Table 1. The average value of BMI increased,
whereas triglycerides and total cholesterol levels decreased from baseline and throughout the
study. The mean age changed less than the time intervals between the studies as a consequence
of people dying or moving from the municipality of Tromsø, and the proportion of men
decreased over time due to a higher mortality rate among men. The most prominent changes
were observed for the proportion of subjects with self-reported diabetes (increased from 2.4%
to 7.1%), the proportion of smokers (decreased from 33.0% to 16.4%), and the proportion of
physically active subjects which increased from 24.2% in 94–95 to 37.9% in 07–08. In addition,
the proportion of subjects with hypertension increased from 49.6% in 94–95 to 67.5% in 07–08
(Table 1). Similar patterns were observedwhen the analyses were restricted to those who par-
ticipated in all three surveys (S1 Table).
Even though the overall changes in blood pressure and blood lipids were small, we observed
large differences when subjects were divided into quintiles according to their baseline value
(Fig 2). In general, the groups in the lowest and highest quintiles at baseline changed the most,
and shifted towards the overall mean. This was a result of both regression towards the mean,
where the most extreme values tend to normalize over time, and measurement errors.
Table 2 shows hazard ratios for MI by the different atherosclerotic risk factors. All risk fac-
tors except one subgroup of BMI (BMI 25–29.9 kg/m2) were significantly associated with MI.
For continuous variables, the differences were generally very small when the risk estimates
based on baselinemeasurements (i.e. time-fixed analysis) were compared with those from
Repeated Measures of Atherosclerotic Risk Factors
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repeated measurements (i.e. time-varying analysis). The largest differences between the two
methods were observed for the categorical variables, and were particularly prominent for the
variables that changed most at the population level, i.e. diabetes, smoking and physical activity.
For MI, the risk estimates associated with diabetes changed from 2.94 (95% CI 2.20–3.92) to
2.11 (95% CI 1.63–2.72), smoking from 1.80 (95% CI 1.55–2.10) to 2.08 (95% CI 1.78–2.42)
and physical activity from 0.74 (95% CI 0.61–0.89) to 0.61 (95% CI 0.50–0.74). Other risk esti-
mates that changed considerably when comparing the two methods were those associated with
hypertension, where the HR changed from 1.90 (95% CI 1.61–2.25) to 1.72 (95% CI 1.44–2.06)
and obesity (BMI30 kg/m2), where the HR changed from 1.43 (95% CI 1.15–1.79) to 1.28
(95% CI 1.04–1.57). The regression dilution correction by Rosner´s method consistently over-
estimated the risk estimates compared with the time-varying analyses (Table 2).
Hazard ratios of VTE according to the different atherosclerotic risk factors are shown in
Table 3. In general, there were only small differences between the risk estimates based on the
time-fixed analysis and those calculatedwith the time-varying analysis. In the time-fixed
model and in the model corrected by Rosners´s method, BMI and hypertension was signifi-
cantly associated with VTE. However, the association between hypertension and VTE disap-
peared when adjusting for BMI in addition to age and sex with HR of 1.24 (95% CI 0.92–1.69)
Table 1. Distribution of traditional atherosclerotic risk factors in the different surveys. In total 5970 were included in the study in 1994/95, and of
these, 5179 and 4391 were re-measured in the 2001–02 and 2007–08, respectively.
The Tromsø Study T4 (1994–1995) T5 (2001–2002) T6 (2007–2008)
Observations (n) 5970 5179 4391
Age, years 56.8 ± 11 62.9 ± 10 67.5 ± 10
Male sex 43.9 42.1 37.7
Systolic BP (mmHg) 141 ± 22 141 ± 21 145 ± 24
Diastolic BP (mmHg) 82 ± 13 81 ± 12 78 ± 11
Hypertension* 51.3 (3064) 56.8 (2941) 68.1 (3008)
Antihypertensive treatment 9.4 (560) 21.2 (1074) 35.2 (1511)
BMI (kg/m2) 25.7 ± 3.9 26.9 ± 4.1 27.0 ± 4.3
<25 kg/m2 46.5 (2775) 35.5 (1827) 34.3 (1503)
25–29.9 kg/m2 40.9 (2441) 44.7 (2302) 45.3 (1984)
30 kg/m2 12.5 (747) 19.9 (1023) 20.4 (894)
Triglycerides (mmol/L) 1.59 ± 1.01 1.53 ± 0.87 1.49 ± 0.81
Total cholesterol (mmol/L) 6.58 ± 1.27 6.28 ± 1.16 5.73 ± 1.13
Hypercholesterolemia † 51.9 (3097) 50.5 (2614) 46.9 (2058)
Lipid lowering drugs 1.8 (83) 12.3 (617) 23.3 (992)
HDL cholesterol (mmol/L) 1.56 ± 0.43 1.49 ± 0.40 1.57 ± 0.46
1.03 (♂) or1.30 (♀) mmol/L 84.0 (5000) 78.6 (4051) 83.4 (3616)
<1.03 (♂) or <1.30 (♀) mmol/L 16.0 (954) 21.4 (1104) 16.6 (722)
Self-reporteddiabetes 2.4 (144) 4.2 (213) 7.1 (302)
Smoking 33.0 (1967) 25.6 (1328) 16.4 (719)
Physical activity | 24.2 (1492) 33.5 (1367) 37.9 (1383)
Education ⁞ 20.0 (1191) 20.6 (1064) 24.1 (1037)
Values are % (n) or mean±SD. BP indicates blood pressure; BMI, body mass index; HDL, high-density lipoprotein.
*Hypertension: systolic BP140 or diastolic BP90 or use of antihypertensive medicine
†Hypercholesterolemia: total cholesterol 6.5 or use of lipid-lowering drugs
|Hard physical activity 1 hour or more every week
⁞Over/equal to 15 years of education (corresponding to 3 years in university or academy)
doi:10.1371/journal.pone.0163242.t001
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and 1.52, (95% CI 0.85–2.73) in the time-fixedmodel and in the model corrected by Rosner´s
method, respectively. When using time-varyinganalysis, only BMI was significantly associated
with VTE (HR 1.21, 95% CI 1.10–1.33, per 3 kg/m2 increase for BMI). For BMI as a continuous
variable and for the overweight subgroup (BMI 25–29.9 kg/m2), the Rosner correction gave slightly
higher risk estimates than the time-varyinganalysis, whereas for obesity (BMI30 kg/m2) the
Rosner correction gave a lower risk estimate than the time-varyinganalysis.
Discussion
In the present study, risk estimates for VTE and MI based on one baselinemeasurement corre-
sponded well with risk estimates based on repeated measurements. Except for BMI, none of the
atherosclerotic risk factors were associated with risk of VTE, neither in the time-fixed nor the
time-varyingmodel. These results suggest that lack of association between several atheroscle-
rotic risk factors and VTE risk in large prospective cohorts could not be explained by regression
dilution bias. For MI, the differences between risk estimates from the time-fixed and the time-
varying analysis were greatest for dichotomous variables that changed much during follow-up,
such as diabetes, smoking and physical activity. Correction of the time-fixed risk estimates
using regression dilution ratios consistently overestimated risk of VTE and MI compared with
the time-varying analysis, suggesting that this type of correction should be used with caution.
Table 2. Age (as time scale)- and sex-adjusted hazard ratios (HR)with 95% confidence intervals (CI) for the risk ofmyocardial infarction (MI) by tra-
ditional atherosclerotic risk factors using three different approaches; time-fixedmodel, time-varyingmodel and correction for regression dilution
throughRosners´smethod. The Tromsø Study 1994–2010.
Risk factors Time-fixedCox-model Time-varying Cox-model Time-fixed model corrected by Rosner´s method
HR (95%CI) HR (95%CI) HR (95%CI)
Male sex 2.46 (2.11–2.87) 2.46 (2.11–2.87) 2.46 (2.11–2.87)
Systolic BP (per 15 mmHg increase) 1.31 (1.23–1.37) 1.23 (1.18–1.29) 1.54 (1.43–1.67)
Diastolic BP (per 10 mmHg increase) 1.26 (1.18–1.32) 1.24 (1.18–1.32) 1.49 (1.35–1.65)
Hypertension* 1.97 (1.66–2.35) 1.73 (1.44–2.07) 3.69 (2.65–5.14)
BMI, 3 units increase (kg/m2) 1.14 (1.08–1.21) 1.10 (1.04–1.16) 1.15 (1.08–1.21)
<25 kg/m2 Ref. Ref. Ref.
25–29.9 kg/m2 1.15 (0.98–1.35) 1.05 (0.89–1.24) 1.17 (0.96–1.43)
30 kg/m2 1.43 (1.15–1.79) 1.28 (1.04–1.57) 1.25 (1.09–1.44)
Triglycerides (mmol/L) 1.21 (1.15–1.28) 1.23 (1.16–1.31) 1.49 (1.33–1.67)
Total cholesterol (mmol/L) 1.22 (1.14–1.29) 1.23 (1.16–1.31) 1.43 (1.28–1.60)
Hypercholesterolemia † 1.44 (1.24–1.68) 1.42 (1.22–1.65) 1.90 (1.45–2.50)
HDL cholesterol (mmol/L) ‡ 0.78 (0.70–0.86) 0.78 (0.70–0.86) 0.71 (0.62–0.81)
1.03 (♂) or1.30 (♀) mmol/L Ref. Ref. Ref.
<1.03 (♂) or <1.30 (♀) mmol/L 1.48 (1.24–1.78) 1.34 (1.12–1.61) 2.06 (1.47–2.89)
Self-reporteddiabetes 2.94 (2.20–3.92) 2.11 (1.63–2.72) 3.17 (2.33–4.32)
Smoking 1.80 (1.55–2.10) 2.08 (1.78–2.42) 2.28 (1.85–2.82)
Physical activity | 0.74 (0.61–0.89) 0.61 (0.50–0.74) 0.40 (0.22–0.70)
Education ⁞ 0.54 (0.43–0.69) 0.55 (0.43–0.69) 0.54 (0.43–0.69)
*Hypertension: systolic BP140 or diastolic BP90 or use of antihypertensive medicine
†Hypercholesterolemia: total cholesterol 6.5 or use of lipid-lowering drugs
‡HDL: per 0.5 mmol/L decrease
|Strenuous physical activity 1 hour or more every week
⁞Over/equal to 15 years of education (corresponding to 3 years in university or academy)
doi:10.1371/journal.pone.0163242.t002
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All the traditional atherosclerotic risk factors were significantly associated with risk of MI in
both the time-fixed and time-varying analysis, and the magnitude of the risk estimates corre-
sponded well to those of previous studies [5, 34]. For VTE, only obesity was associated with
increased risk also in the time-varying approach. Moreover, the risk estimates were lower in
the time-varying than in the time-fixed analyses. This was probably explained by the fact that
most subjects experienced small changes in risk factor levels during follow-up, and conse-
quently, those who changed from one risk category to another would most likely contribute to
the healthiest part of their new, “unhealthy” category. For example, an individual that changed
BMI from 24 to 26 during follow-up would change category from normal weight to overweight
but still be under a relatively low risk of MI and VTE.
While BMI has consistently been shown to increase the risk of VTE, the impact of other ath-
erosclerotic risk factors on VTE risk has been controversial [7, 9, 11, 12, 16, 35]. Case-control
studies have shown associations between serum lipid levels, diabetes, blood pressure and VTE
[11, 13, 15] whereas most cohort studies reported no association [6, 16–18]. While case-control
studies may overestimate risks due to reverse causation, recall bias and selected control groups,
the potential for regression dilution bias (i.e. underestimation or failure to detect a modest
effect that is actually there) has been a major criticism of cohorts with a long follow-up. In the
present study, we showed that the degree of regression dilution was very low for most athero-
sclerotic variables, and that serum lipid levels, smoking, blood pressure and diabetes were not
associated with risk of VTE even in the time-varying approach.
Table 3. Age (as time scale)- and sex-adjusted hazard ratios (HR)with 95% confidence intervals (CI) for the risk of venous thromboembolism
(VTE) by traditionalatherosclerotic risk factors using three different approaches; time-fixedmodel, time-varyingmodel and correction for regres-
sion dilution throughRosners´smethod. The Tromsø Study 1994–2010.
Risk factors Time-fixedCox-model Time-varying Cox-model Time-fixed model corrected by Rosner´s method
HR (95%CI) HR (95%CI) HR (95%CI)
Male sex 1.22 (0.94–1.60) 1.22 (0.94–1.60) 1.22 (0.94–1.63)
Systolic BP (per 15 mmHg increase) 1.06 (0.97–1.18) 1.00 (0.91–1.09) 1.12 (0.96–1.30)
Diastolic BP (per 10 mmHg increase) 1.09 (0.98–1.22) 0.96 (0.86–1.07) 1.17 (0.97–1.42)
Hypertension* 1.41 (1.05–1.89) 1.16 (0.86–1.58) 1.94 (1.10–3.40)
BMI, 3 units increase (kg/m2) 1.24 (1.13–1.37) 1.21 (1.10–1.33) 1.25 (1.13–1.38)
<25 kg/m2 Ref. Ref. Ref.
25–29.9 kg/m2 1.40 (1.03–1.90) 1.10 (0.80–1.51) 1.44 (1.00–2.07)
30 kg/m2 2.08 (1.42–3.05) 1.77 (1.24–2.53) 1.56 (1.23–1.98)
Triglycerides (mmol/L) 1.00 (0.87–1.15) 0.97 (0.83–1.14) 1.00 (0.75–1.33)
Total cholesterol (mmol/L) 1.07 (0.95–1.19) 0.94 (0.84–1.05) 1.13 (0.92–1.39)
Hypercholesterolemia † 1.17 (0.89–1.55) 1.01 (0.77–1.33) 1.36 (0.83–2.23)
HDL cholesterol (mmol/L) ‡ 0.97 (0.82–1.14) 0.85 (0.71–1.01) 0.95 (0.76–1.20)
1.03 (♂) or1.30 (♀) mmol/L Ref. Ref. Ref.
<1.03 (♂) or <1.30 (♀) mmol/L 0.84 (0.56–1.25) 1.27 (0.91–1.76) 0.73 (0.35–1.51)
Self-reporteddiabetes 1.43 (0.71–2.91) 1.41 (0.82–2.42) 1.47 (0.69–3.14)
Smoking 1.20 (0.90–1.61) 1.08 (0.79–1.49) 1.30 (0.86–1.96)
Physical activity | 0.98 (0.70–1.36) 1.02 (0.74–1.42) 0.93 (0.34–2.56)
Education ⁞ 1.07 (0.75–1.54) 1.10 (0.77–1.57) 1.07 (0.75–1.54)
*Hypertension: systolic BP140 or diastolic BP90 or use of antihypertensive medicine
†Hypercholesterolemia: total cholesterol 6.5 or use of lipid-lowering drugs
‡HDL: per 0.5 mmol/L decrease
|Strenuous physical activity 1 hour or more every week
⁞Over/equal to 15 years of education (corresponding to 3 years in university or academy
doi:10.1371/journal.pone.0163242.t003
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Regression dilution was only prominent for yes/no-variables that were strongly associated
with MI and had a high degree of intra-individual change during follow-up, such as smoking
and physical activity. The percentage of smokers decreased from 33% in Tromsø 4 to 16% in
Tromsø 6, and those who stopped smoking during follow-up were misclassified as smokers
during the remaining follow-up in the time-fixedmodel. As these subjects had a reduced risk
of MI, the association between smoking and MI was diluted. Additionally, subjects still smok-
ing in Tromsø 6 had smoked for a longer time, and could therefore have been at greater risk of
MI. The percentage of physically active subjects increased from 24% in Tromsø 4 to 38% in
Tromsø 6, and consequently, the protective effect of physical activity on MI risk was underesti-
mated in the time-fixed analysis.
In regression models with only a single risk factor, the effect of non-differentialmisclassifi-
cation is always to reduce the magnitude of the association [19]. However, in multiple regres-
sion models, including several risk factors or confounders, non-differential misclassification
can actually influence the risk estimates in both directions [36]. In fact, we observed that for
some variables the use of a time-varying analysis actually reduced the risk estimates of MI and
VTE compared with the time-fixed analysis, whereas Rosner´s method consistently overesti-
mated the risk. The change in risk over time is not only a result of time-dependent covariates,
but also influenced by time-dependent effects, and ageing of study participants, change in con-
founder status, change in environment, or improved treatment could have influenced the effect
of exposures over time. For instance, many atherosclerotic risk factors are associated with a
higher relative risk of MI in younger adults than in the elderly [37, 38]. In the case of diabetes
and risk of MI, the risk was lower in the time varying analysis (HR 2.11) than in the time-fixed
analysis (HR 2.94), whereas Rosner´smethod showed a substantially higher risk estimate (HR
3.37). The effect of diabetes on the risk of MI varies not only with age and with other confound-
ers, but also with time as the treatment has improved during the last decades.Moreover, newly
diagnosed diabetic patients still has a low risk of MI [39, 40], and a higher proportion of newly
diagnosed patients than patients with a long-lasting diabetes might additionally explain the
lower risk in the time-varying analysis.
Our study supports previous studies finding no association between atherosclerotic risk fac-
tors, such as hypertension, serum lipids, diabetes and smoking, and future risk of VTE. The
lack of association between serum lipids and VTE suggests that the possible beneficial effects of
statins on VTE [41] is mediated through pleiotropic effects rather than the lipid-lowering
effect, such as a potential antithrombotic effect [42, 43]. Furthermore, the unfavorable effect of
smoking and favorable effect of strenuous physical exercise on the risk of MI are underesti-
mated when single baselinemeasurements made several years before the event are compared
to repeated measurements. Our study support the importance of simple preventive measures,
such as smoking cessation, exercise and reducing cholesterol to prevent MI, as previously stud-
ied [44, 45].
The main strengths of our study includes the prospective design with participants recruited
from a general population, the high attendance rate and the repeated measurements. The
repeated measurements allowed us to update the participants’ atherosclerotic risk factors dur-
ing follow up, and thus reduce misclassification. Furthermore, the municipality of Tromsø is
served by a single hospital, minimizing the chance of missing cases and loss to follow-up. Addi-
tional use of the National population registry and the National Causes of Death Registry
allowed thorough validation of bothMI and VTE. The study has some limitations. The study is
restricted to a homogenous white population with a certain development of atherosclerotic risk
factors over time. Other populations might have different tendencies, and the findingsmight
therefore not apply to all populations. However, it is likely to assume that many of the same
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trends regarding development in atherosclerotic risk factors are true for most other Western
populations.
In conclusion, risk estimates for MI and VTE based on baselinemeasures and time-fixed
analysis correspondedwell with risk estimates based on repeatedmeasurements and time-vary-
ing analyses. Of the traditional atherosclerotic risk factors, only BMI was associated with VTE
in both time-fixed and time-varying analyses, suggesting that underestimation of risks by
regression dilution bias is not explaining the lack of association between several atherosclerotic
risk factors and VTE risk reported in most prospective cohorts. Our findings suggest that for
atherosclerotic risk factors, risk estimates based on a single measurement are generally reliable
in cohort studies with long follow-up, and misclassification is a problem only in situations
where the association between exposure and outcome is strong and the exposure status varies
greatly during follow-up. Correction of the time-fixed risk estimates using the regression dilu-
tion ratio consistently overestimated the associations compared to the time-varying analyses.
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